Wade M. Junker, Ph.D.
Affiliations: | 2008 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
BiochemistryGoogle:
"Wade Junker"Parents
Sign in to add mentor| Surinder K. Batra | grad student | 2008 | University of Nebraska Medical Center | |
| (Molecular and biological studies of MUC17.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| File N, Carmicheal J, Krasnoslobodtsev AV, et al. (2022) Substituent Effects Impact Surface Charge and Aggregation of Thiophenol-Labeled Gold Nanoparticles for SERS Biosensors. Biosensors. 12 |
| Kshirsagar PG, Gulati M, Junker WM, et al. (2021) Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β). Scientific Reports. 11: 23730 |
| Japp NC, Souchek JJ, Sasson AR, et al. (2021) Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection. Journal of Immunology Research. 2021: 9942605 |
| Mallya K, Haridas D, Seshacharyulu P, et al. (2020) Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biology Open |
| Mallya K, Haridas D, Seshacharyulu P, et al. (2020) Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biology Open |
| Uz M, Kalaga M, Pothuraju R, et al. (2018) Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 294: 237-246 |
| Pothuraju R, Rachagani S, Junker WM, et al. (2018) Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research : Cr. 37: 319 |
| Aithal A, Rauth S, Kshirsagar P, et al. (2018) MUC16 as a Novel Target for Cancer Therapy. Expert Opinion On Therapeutic Targets |
| Aithal A, Junker WM, Kshirsagar P, et al. (2018) Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer. Plos One. 13: e0193907 |
| Orzechowski C, Aithal A, Junker W, et al. (2018) Abstract 3829: Generation and characterization of novel antibodies against the β subunit of MUC4 Immunology. 78: 3829-3829 |